Epstein–Barr virus associated peri-implantitis: a split-mouth study

Clinical Oral Investigations

Volumn 19, Issue 2, 2015, Pages 535-543

  Verdugo, Fernando ^a,b   Castillo, Ana ^c   Castillo, Francisca ^c   Uribarri, Agurne ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Private Practice   (United States)

^c UNIVERSITY OF GRANADA   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Epstein Barr virus infections; Human herpesvirus 4; Microbiology; Peri implantitis; Polymerase chain reaction; Saliva; Treponema denticola

Indexed keywords

AGAR GEL ELECTROPHORESIS; EPSTEIN BARR VIRUS; HUMAN; PATHOGENICITY; PERIIMPLANTITIS; POLYMERASE CHAIN REACTION; VIROLOGY;

ELECTROPHORESIS, AGAR GEL; HERPESVIRUS 4, HUMAN; HUMANS; PERI-IMPLANTITIS; POLYMERASE CHAIN REACTION;

EID: 84938586023     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-014-1250-1     Document Type: Article

References (37)

1. Rotola A, Cassai E, Farina R, Caselli E, Gentili V, Lazzarotto T, Trombelli L (2008) Human herpesvirus 7, Epstein–Barr virus and human cytomegalovirus in periodontal tissues of periodontally diseased and healthy subjects. J Clin Periodontol 35:831–837
2. Saygun I, Nizam N, Keskiner I, Bal V, Kubar A, Açıkel C, Serdar M, Slots J (2011) Salivary infectious agents and periodontal disease status. J Periodontal Res 46:235–239
3. Jankovic S, Aleksic Z, Dimitrijevic B, Lekovic V, Camargo P, Kenney B (2011) Prevalence of human cytomegalovirus and Epstein–Barr virus in subgingival plaque at peri-implantitis, mucositis and healthy sites. A pilot study. Int J Oral Maxillofac Surg 40:271–276
4. Jankovic S, Aleksic Z, Dimitrijevic B, Lekovic V, Milinkovic I, Kenney B (2011) Correlation between different genotypes of human cytomegalovirus and Epstein–Barr virus and peri-implant tissue status. Aus Dent J 56:382–388
5. Verdugo F, Castillo A, Simonian K, Castillo F, Farez-Vidal E, D’addona A (2013) Periodontopathogen and Epstein–Barr virus associated periapical periodontitis may be the source of retrograde infectious peri-impantitis. Clin Implant Dent Relat Res. doi:10.1111/cid.12083
6. Vincent-Bugnas S, Vitale S, Mouline CC, Khaali W, Charbit Y, Mahler P, Prêcheur I, Hofman P, Maryanski JL, Doglio A (2013) EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitis. PLoS ONE. doi:10.1371/journal.pone.0080336
7. Saygun I, Kubar A, Ozdemir A, Yapar M, Slots J (2004) Herpesviral–bacterial interrelationships in aggressive periodontitis. J Periodontal Res 39:207–212
8. Kantarci A, Hasturk H, Van Dyke T (2006) Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 40:144–163
9. Slots J (2010) Herpesviral–bacterial interactions in periodontal diseases. Periodontol 2000 52:117–140
10. Slots J, Saygun I, Sabeti M, Kubar A (2006) Epstein–Barr virus in oral diseases. J Periodontal Res 41:235–244
11. Sugano N, Ikeda K, Oshikawa M, Idesawa M, Tanaka H, Sato S, Ito K (2004) Relationship between Porphyromonas gingivalis, Epstein–Barr virus infection and reactivation in periodontitis. J Oral Sci 46:203–206
12. Saygun I, Kubar A, Ozdemir A, Slots J (2005) Periodontitis lesions are a source of salivary cytomegalovirus and Epstein–Barr virus. J Periodontal Res 40:187–191
13. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA (2009) The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5:1–15
14. Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus. Nat Med 8:594–599
15. Verdugo F, Castillo A, Simonian K, Russo P, D’Addona A, Raffaelli L, Moragues MD, Quindós G, Pontón J (2012) Periodontopathogen and Epstein–Barr virus contamination affects transplanted bone volume in sinus augmentation. J Periodontol 83:162–173
16. Savard M, Gosselin J (2006) Epstein–Barr virus immunossuppression of innate immunity mediated by phagocytes. Virus Res 119:134–145
17. Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ (2008) Epstein–Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol 18:397–408
18. Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338:1741–1751
19. Dal Canto AJ, Virgin HW 4th, Speck SH (2000) Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J Virol 74:11304–11310
20. Adler B, Sinzger C (2009) Endothelial cells in human cytomegalovirus infection: one host cell out of many or a crucial target for virus spread? Thromb Haemost 102:1057–1063
21. Ito T, Yasuda M, Kaneko H, Sasaki H, Kato T, Yajima Y (2013) Clinical evaluation of salivary periodontal pathogen levels by real-time polymerase chain reaction in patients before dental implant treatment. Clin Oral Implant Res. doi:10.1111/clr.12198
22. Reynolds MA (2014) Modifiable risk factors in periodontitis: at the intersection of aging and disease. Periodontol 2000(64):7–19
23. Máximo MB, de Mendonça AC, Renata Santos V, Figueiredo LC, Feres M, Duarte PM (2009) Short-term clinical and microbiological evaluations of peri-implant diseases before and after mechanical anti-infective therapies. Clin Oral Implant Res 20:99–108
24. Tabanella G, Nowzari H, Slots J (2009) Clinical and microbiological determinants of ailing dental implants. Clin Implant Dent Relat Res 11:24–36
25. Ashimoto A, Chen C, Bakker I, Slots J (1996) Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 11:266–273
26. Kubar A, Saygun I, Ozdemir A, Yapar M, Slots J (2005) Real-time PCR quantification of human cytomegalovirus and Epstein–Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. J Periodontal Res 40:97–104
27. Kieff E, Rickinson AB (2007) Epstein–Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 5th edn. Lippincott-Williams & Wilkins, Philadelphia, USA, pp 2603–2654
28. Cho-Yan Lee J, Mattheos N, Nixon KC, Ivanovski S (2012) Residual periodontal pockets are a risk indicator for peri-implantitis in patients treated for periodontitis. Clin Oral Implant Res 23:325–333
29. Swierkot K, Lottholz P, Flores-de-Jacoby L, Mengel R (2012) Mucositis, peri-implantitis, implant success, and survival of implants in patients with treated generalized aggressive periodontitis: 3- to 16-year results of a prospective long-term cohort study. J Periodontol 83:1213–1225
30. Lindhe J, Meyle J, Group D of European Workshop on Periodontology (2008) Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol 35:282–285
31. Esposito M, Grusovin MG, Worthington HV (2012) Treatment of peri-implantitis: what interventions are effective? A Cochrane systematic review. Eur J Oral Implantol 5:S21–S41
32. Sunde PT, Olsen I, Enersen M, Grinde B (2008) Patient with severe periodontitis and subgingival Epstein–Barr virus treated with antiviral therapy. J Clin Virol 42:176–178
33. Persson GR, Samuelsson E, Lindahl C, Renvert S (2010) Mechanical non-surgical treatment of peri-implantitis: a single-blinded randomized longitudinal clinical study. II. Microbiological results. J Clin Periodontol 37:563–573
34. Kumar PS, Mason MR, Brooker MR, O’Brien K (2012) Pyrosequencing reveals unique microbial signatures associated with healthy and failing dental implants. J Clin Periodontol 39:425–433
35. da Silva ES, Feres M, Figueiredo LC, Shibli JA, Ramiro FS, Faveri M (2013) Microbiological diversity of peri-implantitis biofilm by Sanger sequencing. Clin Oral Implant Res. doi:10.1111/clr.12231
36. Hujoel PP, Loesche WJ (1990) Efficiency of split-mouth designs. J Clin Periodontol 17:722–728
37. Kato A, Imai K, Ochiai K, Ogata Y (2013) Higher prevalence of Epstein–Barr virus DNA in deeper periodontal pockets of chronic periodontitis in Japanese patients. PLoS ONE 8(8):e71990